Data from the phase 3 HER2CLIMB-05 study support the FDA approval of tucatinib-based maintenance treatment in HER2-positive metastatic breast cancer.
|Poll|December 18, 2015
Breast Nodule Found in 45-Year-Old Woman
Author(s)Cesar A. Moran, MD
A 45-year-old woman is found to have a breast nodule. What is your diagnosis?
Advertisement
A 45-year-old woman is found to have a breast nodule. According to the histopathology image below, what is your diagnosis?
What is your diagnosis?
Advertisement
Related to this article
In the phase 3 evERA trial, interim overall survival data showed a positive trend in favor of giredestrant/everolimus vs endocrine therapy plus everolimus.
Advertisement
Advertisement
Trending on CancerNetwork
1
BNT113/Pembrolizumab Misses PFS End Point in HPV16+ Head and Neck Cancer
2
RYZ101 Improves Progression-Free Survival in Previously Treated GEP-NETs
3
Teclistamab Vs Talquetamab After Relapse on CAR T-Cell Therapy in Multiple Myeloma
4
How Might IMiD Holding Therapy Impact Outcomes in R/R Multiple Myeloma?
5